Hrt Financial LP Novartis Ag Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Novartis Ag stock. As of the latest transaction made, Hrt Financial LP holds 19,846 shares of NVS stock, worth $2.06 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

19,846

Holding current value

$2.06 Million

% of portfolio

0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$106.13 - $120.89 $2.11 Million - $2.4 Million	19,846 New	19,846 $2.28 Million
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $395,876 - $439,338	4,179 New	4,179 $425,000
Q4 2022 Feb 10, 2023	BUY	$75.55 - $92.52 $284,219 - $348,060	3,762 New	3,762 $341,000
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $1.29 Million - $1.5 Million	-16,038 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $454,624 - $514,268	-5,675 Reduced 26.14%	16,038 $1.41 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $493,103 - $545,260	-6,187 Reduced 22.18%	21,713 $1.9 Million
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $2.28 Million - $2.65 Million	27,900 New	27,900 $2.28 Million
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $2.03 Million - $2.25 Million	-23,848 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$83.5 - $98.47 $1.14 Million - $1.34 Million	13,625 Added 133.28%	23,848 $2.04 Million
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $798,109 - $965,357	10,223 New	10,223 $965,000
Q4 2018 Feb 15, 2019	SELL	$73.66 - $82.02 $194,683 - $216,778	-2,643 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$66.94 - $77.43 $176,922 - $204,647	2,643 New	2,643 $227,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account